Examples of 'mycophenolate' in a sentence
Meaning of "mycophenolate"
Mycophenolate (noun): A medication used to prevent organ rejection in transplant patients by suppressing the immune system
Show more definitions
- Any salt or ester of mycophenolic acid.
How to use "mycophenolate" in a sentence
Basic
Advanced
mycophenolate
Mycophenolate causes birth defects and miscarriage.
This is the case of azathioprine and mycophenolate.
Mycophenolate mofetil should be administered on an empty stomach.
One patient also received mycophenolate treatment.
Mycophenolate mofetil was added and dispersed.
These drugs include cyclophosphamide and mycophenolate.
Background information on mycophenolate mofetil teratogenicity and mutagenicity in humans.
Myfenax is a medicine containing the active substance mycophenolate mofetil.
Mycophenolate is a powerful human teratogen.
The active substance is mycophenolate mofetil.
Mycophenolate mofetil was progressively reintroduced.
Promising results are achieved with mycophenolate and tocilizumab.
The combination of mycophenolate and corticosteroids can also be considered.
The active substance in this medicine is called mycophenolate mofetil.
Mycophenolate mofetil and infliximab have been used in select cases.
See also
Myclausen contains mycophenolate mofetil.
Mycophenolate is used for the prevention of organ transplant rejection.
Data confirms mycophenolate is a teratogen.
Mycophenolate mofetil is another option.
Remission of proteinuria occurred only after use of mycophenolate mofetil.
Pharmacokinetic behaviour of mycophenolate in the elderly has not been formally evaluated.
Mycophenolate mofetil has been shown to be excreted in the milk of lactating rats.
Altered by mycophenolate mofetil.
Mycophenolate mofetil is a prodrug.
Rifampicin or mycophenolate mofetil.
Cases of spontaneous abortions have been reported in patients exposed to mycophenolate mofetil.
Myfenax mycophenolate mofetil.
Myclausen is a medicine that contains the active substance mycophenolate mofetil.
The exact role of mycophenolate vs azathioprine has yet to be conclusively established.
Another advantage in relation to azathioprine is that mycophenolate mofetil is less mutagenic.
There is no data on mycophenolate mofetil with phosphate binders other than sevelamer.
Medicines used prevent rejection of transplanted organs such as mycophenolate mofetil.
There are no data on mycophenolate mofetil with phosphate binders other than sevelamer.
A pharmaceutical composition comprising an enteric coated pharmaceutically acceptable mycophenolate salt.
There is limited data from the use of mycophenolate mofetil in pregnant women.
Mycophenolate mofetil is metabolised in the liver to the active moiety mycophenolic acid.
In this matter synthetized crystalline mycophenolate mofetil was recrystallized from ethyl acetate.
Mycophenolate prevents the white blood cells from rejecting the transplanted organ.
Sometimes tacrolimus is given instead of ciclosporin and mycophenolate mofetil instead of azathioprine.
Patients also received mycophenolate mofetil another medicine used in the prevention of rejection.
Days after the first one and immediately before starting mycophenolate mofetil.
The parent substance mycophenolate mofetil can be measured systemically during intravenous infusion.
Caution is therefore recommended when administering these drugs concomitantly with mycophenolate mofetil.
Mycophenolate mofetil is a medicine used in organ transplant patients to help prevent organ rejection.
Coverage will be provided as a second line therapy for patients failing mycophenolate mofetil.
Patients on mycophenolate mofetil who develop recurrent infections should have their serum immunoglobulins measured.
The product conformed to the infrared spectrum of a mycophenolate mofetil reference standard material.
The present invention relates to novel pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt.
Mycophenolate mofetil and rituximab might represent alternative options for patients who are nonresponsive to cyclophosphamide.
In a further aspect the invention provides a pharmaceutical composition comprising a coated pharmaceutically acceptable mycophenolate salt.
